Remcom Announces Biomedical Enhancements in XFdtd EM Simulation Software

By DE Editors

Remcom  has added new biomedical features in its XFdtd Release 7 (XF7) for the MR community.   XF7 is Remcoms full wave 3D EM solver for the analysis of complex EM problems and FDTD-based modeling and simulation

  The Bio-Po version of XF7 provides accurate predictions of the interaction of electromagnetic fields with biological tissues and includes important bio-EM calculation capabilities such as automatic saving of all steady state conduction currents, electric fields, and magnetic fields. In addition, XF7 Bio-Pro includes automatic calculation of Specific Absorption Rate (SAR) including whole body, 1 gram, and 10 gram averages. It can be used for a number of applications, including: imaging devices including MRI coil design and tuning, SAR and field analysis, implantable devices such as pacemakers and diagnostic equipment, field exposure from radiating sources such as cell phones and other antennas, human models and phantoms, and regulation/certification.

The company’s Birdcage Designer and MR Phased Array Designer, which are scheduled for release later this year, provide an intuitive design process, can manage circuit components automatically, and provide automatic grid definition.

The Birdcage and MR Phased Array Designers were developed to allow MR professionals to spend more time investigating possible designs by eliminating the time required to prepare a design for simulation,” said Jim Stack,  Remcom’s training, applications, and consulting manager. “The tools allow users to quickly configure their structures using intuitive settings. The software then automatically adds feeds, capacitors and other project settings. This permits users to move immediately into simulation and tuning. As is typical for any new feature in XF7, our goal was to shorten the time required to successfully complete a design by better reflecting a real world workflow in our process.

For more information, visit Remcom.

Sources: Press materials received from the company and additional information gleaned from the company’s website.